AstraZeneca PLCSEC Filings
|
|
All SEC filings by AstraZeneca PLC (AZN) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 20-F | Annual report (foreign) | View Diff | Feb 24, 2026 | |
| 20-F | Annual report (foreign) | View Diff | Feb 18, 2025 | |
| 20-F | Annual report (foreign) | View Diff | Feb 20, 2024 | |
| 20-F | Annual report (foreign) | View Diff | Feb 21, 2023 | |
| 20-F | Annual report (foreign) | View Diff | Feb 22, 2022 | |
| 20-F | Annual report (foreign) | View Diff | Feb 16, 2021 | |
| 20-F | Annual report (foreign) | View Diff | Mar 3, 2020 | |
| 20-F | Annual report (foreign) | View Diff | Mar 5, 2019 | |
| 20-F | Annual report (foreign) | View Diff | Mar 6, 2018 | |
| 20-F | Annual report (foreign) | View Diff | Mar 7, 2017 |
Events
| 6-K | Current report (foreign) | Oct 5, 2026 | ||
| 6-K | Current report (foreign) | Oct 2, 2026 | ||
| 6-K | Current report (foreign) | Oct 1, 2026 | ||
| 6-K | Current report (foreign) | Oct 1, 2026 | ||
| 6-K | Current report (foreign) | Sep 29, 2026 | ||
| 6-K | Current report (foreign) | Sep 23, 2026 | ||
| 6-K | Current report (foreign) | Sep 21, 2026 | ||
| 6-K | Current report (foreign) | Sep 21, 2026 | ||
| 6-K | Current report (foreign) | Sep 18, 2026 | ||
| 6-K | Current report (foreign) | Sep 15, 2026 |
Registrations and Prospectuses
| 25-NSE | Exchange delisting | May 28, 2026 | ||
| 25-NSE | Exchange delisting | Apr 8, 2026 | ||
| 8-A12B | Registration of securities on exchange | Mar 3, 2026 | ||
| 424B2 | Prospectus for primary offering | Feb 27, 2026 | ||
| FWP | Free writing prospectus | Feb 25, 2026 | ||
| FWP | Free writing prospectus | Feb 25, 2026 | ||
| 424B2 | Prospectus for primary offering | Feb 25, 2026 | ||
| S-8 | Registration of securities for employees | Feb 3, 2026 | ||
| 25 | Voluntary exchange delisting | Jan 30, 2026 | ||
| 8-A12B | Registration of securities on exchange | Jan 22, 2026 |
Proxies
| DFAN14A | Additional proxy materials by non-management | Mar 19, 2024 |
Other
| CERT | Certification of approval for exchange listing | Mar 4, 2026 | ||
| IRANNOTICE | Disclosure regarding Iran Threat Reduction and Syria Human Rights Act | Feb 24, 2026 | ||
| CERT | Certification of approval for exchange listing | Jan 22, 2026 | ||
| CERT | Certification of approval for exchange listing | Jan 22, 2026 | ||
| IRANNOTICE | Disclosure regarding Iran Threat Reduction and Syria Human Rights Act | Feb 18, 2025 | ||
| EFFECT | Notice of effectiveness | Feb 6, 2025 | ||
| CERT | Certification of approval for exchange listing | Mar 6, 2024 | ||
| IRANNOTICE | Disclosure regarding Iran Threat Reduction and Syria Human Rights Act | Feb 20, 2024 | ||
| CORRESP | Correspondence with SEC | Jan 10, 2024 | ||
| CERT | Certification of approval for exchange listing | Mar 15, 2023 |
Ownership
| 4 | Sharma Mani | 14h ago | ||
| 4 | Sharma Mani | Sep 11, 2026 | ||
| 4 | Sharma Mani | Aug 7, 2026 | ||
| 4 | Sharma Mani | Jul 8, 2026 | ||
| 11-K | Annual report of employee stock purchases | Jun 29, 2026 | ||
| 4 | Sharma Mani | Jun 16, 2026 | ||
| 4 | Mani Sharma | May 22, 2026 | ||
| 4 | Mani Sharma | May 8, 2026 | ||
| SC 13G | Vanguard Capital Management Llc Acquires 5.02% Stake in Astrazeneca Plc | Apr 28, 2026 | ||
| 3 | Mani Sharma | Mar 19, 2026 |